BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11345369)

  • 1. Overutilization and underutilization of thrombolysis in routine clinical practice.
    Sleight P
    J Am Coll Cardiol; 2001 May; 37(6):1588-9. PubMed ID: 11345369
    [No Abstract]   [Full Text] [Related]  

  • 2. Consequences of overutilization and underutilization of thrombolytic therapy in clinical practice. TRACE Study Group. TRAndolapril Cardiac Evaluation.
    Ottesen MM; Køber L; Jørgensen S; Torp-Pedersen C
    J Am Coll Cardiol; 2001 May; 37(6):1581-7. PubMed ID: 11345368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of regional cardiovascular mortality on the use of angiography after acute myocardial infarction.
    McCullough PA; O'Neill WW
    Am J Cardiol; 1997 Mar; 79(5):575-80. PubMed ID: 9068511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarction.
    Sobel BE; Collen D
    Am J Cardiol; 1993 Feb; 71(5):424-7. PubMed ID: 8430631
    [No Abstract]   [Full Text] [Related]  

  • 5. Rural Alberta thrombolysis study. Survey of practice patterns for managing acute myocardial infarction.
    Hindle H; Norheim JK; Renger R
    Can Fam Physician; 1995 Jul; 41():1180-7. PubMed ID: 7647623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
    Hiatt MD
    Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
    Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
    Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in thrombolysis--choice of the agent.
    Horak AR; Commerford PJ
    S Afr Med J; 1990 Jan; 77(2):60-1. PubMed ID: 2104993
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy.
    Brody B; Wray N; Bame S; Ashton C; Petersen N; Harward M
    Med Care; 1991 Sep; 29(9):899-910. PubMed ID: 1921539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis after acute myocardial infarction.
    Wald D
    Lancet; 1997 May; 349(9064):1551. PubMed ID: 9167479
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic treatment for elderly patients with acute myocardial infarction.
    Estess JM; Topol EJ
    Heart; 2002 Apr; 87(4):308-11. PubMed ID: 11906993
    [No Abstract]   [Full Text] [Related]  

  • 14. Is time running out on streptokinase?
    Sane DC; Little WC
    J Am Coll Cardiol; 1998 Mar; 31(4):780-2. PubMed ID: 9525546
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic therapy in acute myocardial infarction: practice pattern at an Arab Middle Eastern centre.
    Zubaid M; Rashed WA
    Acta Cardiol; 2001 Apr; 56(2):115-9. PubMed ID: 11357923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of thrombolytic therapy in the management of acute myocardial infarction.
    Hlatky MA; Cotugno H; O'Connor C; Mark DB; Pryor DB; Califf RM
    Am J Cardiol; 1988 Mar; 61(8):510-4. PubMed ID: 3125736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Stebbins AL; Granger CB; Suarez LD; Borruel M; Gates K; Starr S; Wagner GS
    J Am Coll Cardiol; 1997 Mar; 29(4):770-7. PubMed ID: 9091523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.